Skip to content
← Full study record

NCT01946152 · MORE INFO

Limitations, agreements, and source contact

Pomalidomide, Dexamethasone, and Filgrastim-sndz in Treating Patients With Relapsed or Refractory Multiple Myeloma · Source last updated 2021-07-30

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
miwang@mdanderson.org
organization
UT MD Anderson Cancer Center
phone
(713) 792-2860
title
Michael Wang,MD/ Professor, Lymphoma-Myeloma
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
miwang@mdanderson.org
organization
UT MD Anderson Cancer Center
phone
(713) 792-2860
title
Michael Wang,MD/ Professor, Lymphoma-Myeloma

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice